openPR Logo
Press release

Pain Management Devices Market Poised to Reach USD 32.19 Billion by 2034 with a 10.68% CAGR: DelveInsight | Abbott, Medtronic, and Boston Scientific

04-16-2026 07:52 PM CET | Health & Medicine

Press release from: DelveInsight

Pain Management Devices Market Insight

Pain Management Devices Market Insight

The global pain management devices market is witnessing significant transformation, propelled by the rising prevalence of chronic pain conditions, a strategic shift away from opioid-based therapies, and rapid technological integration such as AI-driven neuromodulation and wearable solutions.

Key Takeaways

• February 2026: CURAPOD raised USD 2.2 million in a pre-series A funding round to scale its wearable pain management technology.
• May 2025: Matri launched Matri Pro, a wearable device designed to provide instant relief from menstrual cramps.
• April 2025: Nutrify introduced DigiVibe, a handheld device to manage pain associated with hormone injections during fertility treatments.
• The global pain management devices market size, valued at USD 12.92 billion in 2025, is projected to reach USD 32.19 billion by 2034, growing at a CAGR of 10.68% from 2026 to 2034.
• North America leads the global market, accounting for a 77.29% share in 2025, driven by high chronic pain prevalence, a robust pipeline of FDA approvals, and favorable reimbursement policies.
• The primary growth drivers include the increasing global geriatric population, rising incidences of chronic diseases like cancer and diabetes-related neuropathy, and the urgent need for non-pharmacological alternatives amidst the opioid crisis.
• Technological advancements such as AI-powered personalized therapy algorithms, miniaturized implantable neurostimulators, and closed-loop systems are enhancing device efficacy and patient acceptance.
• By product type, neurostimulation devices dominate the market with a share of more than 60% in 2026, while radiofrequency ablation is projected to exhibit the fastest growth due to its minimally invasive nature.
• Neuropathic pain is the leading application segment, holding approximately 35% of the market share in 2026, followed closely by cancer pain management.
• Major industry players include Abbott Laboratories, Medtronic, Boston Scientific Corporation, Nevro Corp, Stryker, and Biotronik, who are actively expanding their portfolios through strategic acquisitions and AI-driven innovations.

For more recent advancements in this landscape, visit Pain Management Devices Market Recent Developments @ https://www.delveinsight.com/sample-request/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Pain Management Devices Market Overview and Growth Outlook

The global pain management devices market is forecast to grow from USD 14.30 billion in 2026 to USD 32.19 billion by 2034, reflecting a robust CAGR of 10.68%. This growth trajectory is sustained by a secular rise in chronic conditions such as osteoarthritis, orthopedic degenerative diseases, and diabetic neuropathy, alongside a global healthcare paradigm shift toward drug-free, personalized therapy options.

Dive deeper into the Pain Management Devices market trends @ https://www.delveinsight.com/sample-request/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Pain Management Devices Market Regional Insights

North America is anticipated to maintain its leadership, holding a significant 44.3% market share in 2026, supported by high per capita income and extensive adoption of premium implantable devices. The region benefits from supportive government initiatives and a strong focus on non-opioid solutions to address the addiction crisis.

Furthermore, the Asia-Pacific region is emerging as the fastest-growing market, fueled by a massive patient base, increasing healthcare expenditure, and improving reimbursement frameworks in countries like Japan. Europe continues to show stable growth due to well-established healthcare systems and high standards for chronic pain care.

For in-depth regional analysis, visit Pain Management Devices Market Regional Analysis and Market Share https://www.delveinsight.com/sample-request/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Pain Management Devices Market Segmentation

• By Product Type: Neurostimulation Devices (Spinal Cord Stimulators, Deep Brain Stimulators, TENS), Ablation Devices (Radiofrequency, Cryoablation), Analgesic Infusion Pumps, Virtual Reality Devices.
• By Application: Neuropathic Pain, Cancer Pain, Musculoskeletal Pain, Arthritic Pain, Post-operative Pain.
• By Geography: North America, Europe, Asia-Pacific, Rest of the World.

Pain Management Devices Market Competitive Landscape

Leading companies in the market include Abbott, Medtronic, Boston Scientific Corporation, Nevro Corp, Stryker, Biotronik, Saluda Medical, and Avanos Medical. These players focus on AI integration, such as Nevro's HFX AdaptivAI and Medtronic's closed-loop stimulation systems, to differentiate their offerings and improve clinical outcomes.

Which company is expected to dominate the Pain Management Devices market? Know @ https://www.delveinsight.com/sample-request/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Key Features of DelveInsight's Pain Management Devices Market Report

• Comprehensive market sizing and forecasts from 2025 to 2034, including revenue projections and detailed CAGR analysis.
• Granular regional assessment across North America, Europe, and Asia-Pacific, highlighting market share and growth hotspots.
• Detailed analysis of core product categories such as neurostimulation, radiofrequency ablation, and infusion pumps.
• Evaluation of end-user segments, including hospitals, clinics, physiotherapy centers, and the growing homecare preference.
• In-depth coverage of market drivers such as the aging global population and the critical shift to non-opioid treatments.
• Strategic insights into the adoption of AI-driven adaptive stimulation systems and miniaturized implantable technologies.
• Identification of challenges, including high surgical costs and stringent regulatory approval processes for innovative systems.
• Competitive intelligence through detailed profiles of major developers and analysis of recent strategic partnerships.

Request Custom Analysis or Speak to Our Analyst @ https://www.delveinsight.com/sample-request/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=xpr

Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email: info@delveinsight.com
Phone: +14699457679
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pain Management Devices Market Poised to Reach USD 32.19 Billion by 2034 with a 10.68% CAGR: DelveInsight | Abbott, Medtronic, and Boston Scientific here

News-ID: 4475351 • Views:

More Releases from DelveInsight

Ovarian Cancer Pipeline Expands with 180+ Companies and 200+ Emerging Therapies, Finds DelveInsight | Genentech, Genmab, AstraZeneca, GSK, Merck, Novartis, Allarity Therapeutics
Ovarian Cancer Pipeline Expands with 180+ Companies and 200+ Emerging Therapies, …
DelveInsight's "Ovarian Cancer - Pipeline Insight, 2026" report provides comprehensive insights about 180+ companies and more than 200 pipeline drugs in the Ovarian Cancer pipeline landscape. It covers the Ovarian Cancer pipeline drug profiles, including clinical and nonclinical stage products, along with therapeutics assessment by product type, stage, route of administration, and molecule type. The report highlights inactive pipeline products and explores the commercial and clinical assessment of products from
Contraceptive Devices Market Projected to Reach USD 32.8 Billion by 2032, Driven by 6.28% CAGR and Rising Global Awareness: DelveInsight | Bayer, Reckitt Benckiser, and Organon
Contraceptive Devices Market Projected to Reach USD 32.8 Billion by 2032, Driven …
The global contraceptive devices market is poised for robust expansion, fueled by increasing awareness of family planning, demographic shifts such as delayed parenthood, and the continuous innovation in long-acting reversible contraceptives (LARCs) that offer high efficacy and fewer side effects across diverse patient populations. Key Takeaways • The global contraceptive devices market is projected to grow from approximately USD 20.2 billion in 2024 to nearly USD 32.8 billion by 2032, reflecting a
Trauma Fixation Devices Market Set for Steady Growth at 6.01% CAGR Through 2032: DelveInsight | DePuy Synthes, Stryker, and Zimmer Biomet
Trauma Fixation Devices Market Set for Steady Growth at 6.01% CAGR Through 2032: …
The global trauma fixation devices market is poised for strong, sustained expansion, driven by rising incidence of road accidents and trauma cases, growing volumes of orthopedic surgeries, and rapid adoption of advanced fixation technologies including bioabsorbable implants, minimally invasive systems, and AI-assisted surgical tools across key geographies. Key Takeaways • The global trauma fixation devices market is projected to grow from USD 8,073.28 million in 2024 to USD 12,795.77 million by 2032,
Cystic Fibrosis Clinical Trial Pipeline Expands as 50+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | Vertex Pharmaceuticals, Armata Pharmaceuticals, Krystal Biotech, 4D Molecular Therapeutics, SpliSense, Verona Pharma
Cystic Fibrosis Clinical Trial Pipeline Expands as 50+ Pharma Companies Progress …
DelveInsight's "Cystic Fibrosis - Pipeline Insight, 2026" report provides comprehensive insights about 50+ companies developing 55+ pipeline drugs in the Cystic Fibrosis pipeline landscape. It covers the Cystic Fibrosis pipeline drug profiles, including clinical and nonclinical stage products, along with therapeutics assessment by product type, stage, route of administration, and molecule type, and further highlights inactive pipeline products in this space. Explore the latest breakthroughs in the Cystic Fibrosis treatment landscape.

All 5 Releases


More Releases for Pain

Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain. Personalized Treatment for Every Pain Disorder Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe. By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods. So, have a pain-free life with easy-to-use pain relief
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033. The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments. Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction: The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes. In this article,
Post-Operative Pain Management Market By Type, By Application(Cancer Pain, Arthr …
Global Post-Operative Pain Management Market- Description Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical